Cryo-Cell International, Inc. (CCEL)
USD 5.55
(-4.64%)
USD 5.55
(-4.64%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 72.25 Million USD | 8.79% |
| 2022 | 66.41 Million USD | 17.59% |
| 2021 | 56.47 Million USD | 15.58% |
| 2020 | 48.86 Million USD | -1.95% |
| 2019 | 49.83 Million USD | -2.84% |
| 2018 | 51.29 Million USD | 40.88% |
| 2017 | 36.41 Million USD | 4.18% |
| 2016 | 34.95 Million USD | 42.89% |
| 2015 | 24.46 Million USD | 16.84% |
| 2014 | 20.93 Million USD | 0.81% |
| 2013 | 20.76 Million USD | -2.62% |
| 2012 | 21.32 Million USD | -2.73% |
| 2011 | 21.92 Million USD | 11.23% |
| 2010 | 19.71 Million USD | -0.38% |
| 2009 | 19.78 Million USD | 10.24% |
| 2008 | 17.95 Million USD | -1.5% |
| 2007 | 18.22 Million USD | 8.92% |
| 2006 | 16.73 Million USD | 20.91% |
| 2005 | 13.83 Million USD | 10.92% |
| 2004 | 12.47 Million USD | 13.34% |
| 2003 | 11 Million USD | 175.5% |
| 2002 | 3.99 Million USD | 39.07% |
| 2001 | 2.87 Million USD | 79.37% |
| 2000 | 1.6 Million USD | 220.35% |
| 1999 | 500 Thousand USD | -72.22% |
| 1998 | 1.8 Million USD | 100.0% |
| 1997 | 900 Thousand USD | 80.0% |
| 1996 | 500 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 72.04 Million USD | -0.28% |
| 2024 Q3 | 72.49 Million USD | -1.11% |
| 2024 Q2 | 73.3 Million USD | 1.75% |
| 2023 FY | 72.25 Million USD | 8.79% |
| 2023 Q2 | 69.61 Million USD | 4.18% |
| 2023 Q4 | 72.25 Million USD | 3.49% |
| 2023 Q1 | 66.82 Million USD | 0.62% |
| 2023 Q3 | 69.81 Million USD | 0.28% |
| 2022 Q4 | 66.41 Million USD | -3.96% |
| 2022 Q3 | 69.15 Million USD | 35.62% |
| 2022 Q1 | 50.55 Million USD | -10.48% |
| 2022 Q2 | 50.98 Million USD | 0.85% |
| 2022 FY | 66.41 Million USD | 17.59% |
| 2021 Q3 | 54.62 Million USD | 0.57% |
| 2021 FY | 56.47 Million USD | 15.58% |
| 2021 Q1 | 106.95 Million USD | 118.89% |
| 2021 Q2 | 54.31 Million USD | -49.22% |
| 2021 Q4 | 56.47 Million USD | 3.39% |
| 2020 Q1 | 50.73 Million USD | 1.79% |
| 2020 Q2 | 49.82 Million USD | -1.79% |
| 2020 Q3 | 48.47 Million USD | -2.7% |
| 2020 Q4 | 48.86 Million USD | 0.8% |
| 2020 FY | 48.86 Million USD | -1.95% |
| 2019 Q1 | 51.57 Million USD | 0.54% |
| 2019 Q2 | 48.98 Million USD | -5.03% |
| 2019 FY | 49.83 Million USD | -2.84% |
| 2019 Q3 | 48.79 Million USD | -0.39% |
| 2019 Q4 | 49.83 Million USD | 2.15% |
| 2018 Q4 | 51.29 Million USD | -2.29% |
| 2018 FY | 51.29 Million USD | 40.88% |
| 2018 Q3 | 52.49 Million USD | 44.54% |
| 2018 Q2 | 36.32 Million USD | 0.15% |
| 2018 Q1 | 36.26 Million USD | -0.4% |
| 2017 Q4 | 36.41 Million USD | 4.87% |
| 2017 FY | 36.41 Million USD | 4.18% |
| 2017 Q1 | 34.66 Million USD | -0.82% |
| 2017 Q2 | 35.32 Million USD | 1.89% |
| 2017 Q3 | 34.72 Million USD | -1.7% |
| 2016 Q4 | 34.95 Million USD | 1.14% |
| 2016 Q2 | 25.07 Million USD | 2.61% |
| 2016 FY | 34.95 Million USD | 42.89% |
| 2016 Q3 | 34.55 Million USD | 37.82% |
| 2016 Q1 | 24.43 Million USD | -0.1% |
| 2015 Q4 | 24.46 Million USD | 0.82% |
| 2015 Q2 | 21.63 Million USD | 4.02% |
| 2015 Q3 | 24.26 Million USD | 12.15% |
| 2015 FY | 24.46 Million USD | 16.84% |
| 2015 Q1 | 20.8 Million USD | -0.65% |
| 2014 Q3 | 20.32 Million USD | 1.66% |
| 2014 Q4 | 20.93 Million USD | 3.0% |
| 2014 Q2 | 19.99 Million USD | 2.01% |
| 2014 FY | 20.93 Million USD | 0.81% |
| 2014 Q1 | 19.59 Million USD | -5.63% |
| 2013 Q1 | 21.05 Million USD | -1.3% |
| 2013 Q4 | 20.76 Million USD | 1.39% |
| 2013 FY | 20.76 Million USD | -2.62% |
| 2013 Q3 | 20.48 Million USD | -4.07% |
| 2013 Q2 | 21.35 Million USD | 1.43% |
| 2012 Q2 | 20.8 Million USD | -1.35% |
| 2012 Q3 | 20.89 Million USD | 0.46% |
| 2012 Q1 | 21.08 Million USD | -3.83% |
| 2012 FY | 21.32 Million USD | -2.73% |
| 2012 Q4 | 21.32 Million USD | 2.05% |
| 2011 Q4 | 21.92 Million USD | 4.55% |
| 2011 Q2 | 19.71 Million USD | 1.86% |
| 2011 Q1 | 19.35 Million USD | -1.83% |
| 2011 FY | 21.92 Million USD | 11.23% |
| 2011 Q3 | 20.97 Million USD | 6.39% |
| 2010 Q2 | 19.59 Million USD | 0.93% |
| 2010 FY | 19.71 Million USD | -0.38% |
| 2010 Q1 | 19.41 Million USD | -1.9% |
| 2010 Q4 | 19.71 Million USD | -0.12% |
| 2010 Q3 | 19.73 Million USD | 0.73% |
| 2009 Q2 | 18.25 Million USD | 1.95% |
| 2009 Q3 | 18.96 Million USD | 3.89% |
| 2009 Q4 | 19.78 Million USD | 4.35% |
| 2009 FY | 19.78 Million USD | 10.24% |
| 2009 Q1 | 17.9 Million USD | -0.26% |
| 2008 Q4 | 17.95 Million USD | -0.25% |
| 2008 Q3 | 17.99 Million USD | 0.19% |
| 2008 FY | 17.95 Million USD | -1.5% |
| 2008 Q1 | 17.46 Million USD | -4.16% |
| 2008 Q2 | 17.96 Million USD | 2.83% |
| 2007 Q4 | 18.22 Million USD | 6.76% |
| 2007 FY | 18.22 Million USD | 8.92% |
| 2007 Q3 | 17.07 Million USD | 0.03% |
| 2007 Q2 | 17.06 Million USD | 4.44% |
| 2007 Q1 | 16.34 Million USD | -2.34% |
| 2006 FY | 16.73 Million USD | 20.91% |
| 2006 Q1 | 14.23 Million USD | 2.89% |
| 2006 Q3 | 15.87 Million USD | 6.28% |
| 2006 Q4 | 16.73 Million USD | 5.37% |
| 2006 Q2 | 14.94 Million USD | 4.93% |
| 2005 Q1 | 12.45 Million USD | -0.21% |
| 2005 FY | 13.83 Million USD | 10.92% |
| 2005 Q4 | 13.83 Million USD | 7.44% |
| 2005 Q3 | 12.88 Million USD | 1.16% |
| 2005 Q2 | 12.73 Million USD | 2.27% |
| 2004 Q4 | 12.47 Million USD | 8.67% |
| 2004 Q2 | 12.19 Million USD | 3.76% |
| 2004 Q1 | 11.75 Million USD | 6.74% |
| 2004 FY | 12.47 Million USD | 13.34% |
| 2004 Q3 | 11.48 Million USD | -5.83% |
| 2003 FY | 11 Million USD | 175.5% |
| 2003 Q1 | 9.88 Million USD | 147.27% |
| 2003 Q3 | 10.33 Million USD | -16.2% |
| 2003 Q2 | 12.32 Million USD | 24.76% |
| 2003 Q4 | 11 Million USD | 6.56% |
| 2002 FY | 3.99 Million USD | 39.07% |
| 2002 Q4 | 3.99 Million USD | 11.39% |
| 2002 Q2 | 2.96 Million USD | 4.9% |
| 2002 Q3 | 3.58 Million USD | 20.83% |
| 2002 Q1 | 2.83 Million USD | -1.49% |
| 2001 FY | 2.87 Million USD | 79.37% |
| 2001 Q1 | 1.66 Million USD | 4.1% |
| 2001 Q2 | 1.43 Million USD | -14.09% |
| 2001 Q4 | 2.87 Million USD | 117.84% |
| 2001 Q3 | 1.31 Million USD | -7.92% |
| 2000 Q2 | 614.84 Thousand USD | 6.24% |
| 2000 FY | 1.6 Million USD | 220.35% |
| 2000 Q1 | 578.75 Thousand USD | 15.75% |
| 2000 Q3 | 1.55 Million USD | 152.56% |
| 2000 Q4 | 1.6 Million USD | 3.15% |
| 1999 Q1 | 700 Thousand USD | -61.11% |
| 1999 FY | 500 Thousand USD | -72.22% |
| 1999 Q2 | 700 Thousand USD | 0.0% |
| 1999 Q3 | 700 Thousand USD | 0.0% |
| 1999 Q4 | 500 Thousand USD | -28.57% |
| 1998 Q3 | 1.1 Million USD | 10.0% |
| 1998 Q1 | 900 Thousand USD | 0.0% |
| 1998 Q2 | 1 Million USD | 11.11% |
| 1998 FY | 1.8 Million USD | 100.0% |
| 1998 Q4 | 1.8 Million USD | 63.64% |
| 1997 FY | 900 Thousand USD | 80.0% |
| 1997 Q1 | 600 Thousand USD | 20.0% |
| 1997 Q4 | 900 Thousand USD | -30.77% |
| 1997 Q3 | 1.3 Million USD | 116.67% |
| 1997 Q2 | 600 Thousand USD | 0.0% |
| 1996 FY | 500 Thousand USD | 0.0% |
| 1996 Q4 | 500 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 97.076% |
| Addus HomeCare Corporation | 317.73 Million USD | 77.26% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | 44.233% |
| Amedisys, Inc. | 940.38 Million USD | 92.317% |
| American Oncology Network, Inc. | 368.72 Million USD | 80.405% |
| Astrana Health, Inc. | 522.59 Million USD | 86.174% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 95.905% |
| IMAC Holdings, Inc. | 1.89 Million USD | -3709.221% |
| biote Corp. | 191.84 Million USD | 62.338% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | 64.913% |
| COMPASS Pathways plc | 50.24 Million USD | -43.805% |
| DocGo Inc. | 185.28 Million USD | 61.004% |
| The Ensign Group, Inc. | 2.68 Billion USD | 97.304% |
| Healthcare Services Group, Inc. | 346.56 Million USD | 79.152% |
| InnovAge Holding Corp. | 247.85 Million USD | 70.849% |
| Assure Holdings Corp. | 22.84 Million USD | -216.215% |
| The Joint Corp. | 62.37 Million USD | -15.827% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 91.017% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -1795.8% |
| ModivCare Inc. | 1.61 Billion USD | 95.515% |
| NewGenIvf Group Limited | 1.24 Million USD | -5720.039% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -553.039% |
| Option Care Health, Inc. | 1.9 Billion USD | 96.211% |
| P3 Health Partners Inc. | 427.3 Million USD | 83.091% |
| P3 Health Partners Inc. | 427.3 Million USD | 83.091% |
| The Pennant Group, Inc. | 394.17 Million USD | 81.67% |
| Surgery Partners, Inc. | 3.65 Billion USD | 98.024% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -7839.152% |
| Talkspace, Inc. | 23.57 Million USD | -206.477% |
| Talkspace, Inc. | 23.57 Million USD | -206.477% |
| The Oncology Institute, Inc. | 162.39 Million USD | 55.508% |
| The Oncology Institute, Inc. | 162.39 Million USD | 55.508% |